Neuberger Berman High Yield Strategies Fund (NHS) Stock

Online searches for Eli Lilly and Co's (NYSE:LLY) weight loss and diabetes drug Mounjaro have soared more than four-fold since the NHS received approval for weight loss programmes last week. UK drug regulator NICE gave the green light for it to be prescribed alongside diet and exercise advice from March 2025, but said a full roll-out to everyone who wants it will take twelve years.

NEW YORK , Nov. 29, 2024 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on December 31, 2024, has a record date of December 16, 2024, and has an ex-date of December 16, 2024.

NEW YORK , Oct. 31, 2024 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on November 29, 2024, has a record date of November 15, 2024, and has an ex-date of November 15, 2024.

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too expensive for NHS patients, the Telegraph reported on Tuesday.

I recommend holding Neuberger Berman High Yield Strategies for its 12.8% yield, despite its current high premium to NAV. The NHS closed-end fund benefits from lower interest rates, which increase bond prices, and has outperformed peers in total return YTD. The fund's steady monthly distributions and defensive portfolio make it a compelling high-yield income option.

England's National Health Services plans to offer Eli Lilly's weight-loss drugs to nearly a quarter million people as part of a three-year plan, UK's drugs cost regulator said on Thursday.

NEW YORK , Sept. 30, 2024 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock.

The Neuberger Berman High Yield Strategies Fund offers a 13.15% yield, appealing to income-seeking investors but raising concerns about sustainability going forward. The fund primarily invests in junk bonds and has underperformed relevant indices over the past seven months. The fund's leverage ratio has decreased to 27.50%, which is below the peer median, indicating a reasonable use of leverage for its strategy.

NEW YORK , Aug. 30, 2024 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on September 30, 2024, has a record date of September 16, 2024, and has an ex-date of September 16, 2024.